Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
selinexor
×
Clear all
Filters
2
NCT04562389
2025-10-03
SENTRY
Karyopharm Therapeutics Inc
Phase 3
Active not recruiting
353 enrolled